S, C., DJ, W., RK, A., C, C., RF, D., S, H., . . . GA, P. (2025). Comparative Emergence of Maribavir and Ganciclovir Resistance in a Randomized Phase 3 Clinical Trial for Treatment of Cytomegalovirus Infection. The Journal of infectious diseases, 231(3), e470. https://doi.org/10.1093/infdis/jiae469
Chicago Style (17th ed.) CitationS, Chou, et al. "Comparative Emergence of Maribavir and Ganciclovir Resistance in a Randomized Phase 3 Clinical Trial for Treatment of Cytomegalovirus Infection." The Journal of Infectious Diseases 231, no. 3 (2025): e470. https://doi.org/10.1093/infdis/jiae469.
MLA (9th ed.) CitationS, Chou, et al. "Comparative Emergence of Maribavir and Ganciclovir Resistance in a Randomized Phase 3 Clinical Trial for Treatment of Cytomegalovirus Infection." The Journal of Infectious Diseases, vol. 231, no. 3, 2025, p. e470, https://doi.org/10.1093/infdis/jiae469.